EFFECTS OF CORONARY ANGIOPLASTY ON PLASMA PLATELET-ACTIVATING-FACTOR IN MAN

被引:0
|
作者
ELDAR, M
LYSKO, PG
SCHULHOFF, N
GAGNON, RC
FEUERSTEIN, G
SHANI, J
机构
[1] MAIMONIDES HOSP,DEPT CARDIOL,BROOKLYN,NY 11219
[2] SMITHKLINE BEECHAM PHARMACEUT,DEPT PHARMACOL,KING OF PRUSSIA,PA
来源
JOURNAL OF LIPID MEDIATORS | 1992年 / 5卷 / 03期
关键词
PAF; CORONARY ANGIOPLASTY; ISCHEMIA; MYOCARDIAL;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet activating factor (PAF) is a mediator of ischemia and reperfusion-induced tissue damage which was found to be synthesized in culture by endothelial cells. We hypothesized that PAF levels may be increased in the coronary system following coronary angioplasty. PAF levels were measured in the great cardiac vein of 16 patients before, during and following angioplasty of the left anterior coronary artery. PAF concentration was significantly higher in the cardiac vein than in the peripheral circulation at all time points. Interestingly, while PAF levels tended to decrease in the periphery they tended to increase in the coronary system over time. We conclude that PAF levels are higher in the coronary system than in the peripheral circulation in patients undergoing coronary angioplasty and that PAF may be released into the coronary artery following the procedure.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 50 条
  • [1] PLASMA MEDIATED NEUTROPHIL STIMULATION DURING CORONARY ANGIOPLASTY - AUTOCRINE EFFECT OF PLATELET-ACTIVATING-FACTOR
    SIMINIAK, T
    OGORMAN, DJ
    SHAHI, M
    HACKETT, D
    SHERIDAN, DJ
    BRITISH HEART JOURNAL, 1995, 74 (06): : 625 - 630
  • [2] THE METABOLIC EFFECTS OF PLATELET-ACTIVATING-FACTOR ANTAGONISM IN ENDOTOXEMIC MAN
    THOMPSON, WA
    COYLE, S
    VANZEE, K
    OLDENBURG, H
    TROUSDALE, R
    ROGY, M
    FELSEN, D
    MOLDAWER, L
    LOWRY, SF
    MAIER, R
    WITTMANN, D
    ARCHIVES OF SURGERY, 1994, 129 (01) : 72 - 79
  • [3] SALBUTAMOL INHIBITS PULMONARY EFFECTS OF PLATELET-ACTIVATING-FACTOR IN MAN
    ROCA, J
    FELEZ, MA
    CHUNG, KF
    BARBERA, JA
    ROTGER, M
    SANTOS, C
    RODRIGUEZROISIN, R
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (06) : 1740 - 1744
  • [4] INACTIVATION BY PLASMA OF PLATELET-ACTIVATING-FACTOR
    SATOH, K
    TAKAMATSU, S
    ACTA HAEMATOLOGICA JAPONICA, 1986, 49 (03): : 711 - 716
  • [5] CARDIOVASCULAR EFFECTS OF PLATELET-ACTIVATING-FACTOR
    HOLLAND, MR
    MCINTYRE, TM
    ZIMMERMAN, GA
    PRESCOTT, SM
    TRENDS IN CARDIOVASCULAR MEDICINE, 1991, 1 (03) : 117 - 121
  • [6] EFFECTS OF PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTS ON INTRACELLULAR PLATELET-ACTIVATING-FACTOR FUNCTION IN NEUTROPHILS
    KOIKE, H
    IMANISHI, N
    NATSUME, Y
    MOROOKA, S
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (03): : 299 - 309
  • [7] CARDIOVASCULAR EFFECTS OF PLATELET-ACTIVATING-FACTOR
    GOLDSTEIN, RE
    FEUERSTEIN, GZ
    BRADLEY, LM
    STAMBOULY, JJ
    LAURINDO, FRM
    DAVENPORT, NJ
    LIPIDS, 1991, 26 (12) : 1250 - 1256
  • [8] ENDOTHELIUM-DEPENDENT EFFECTS OF PLATELET-ACTIVATING-FACTOR IN THE CORONARY CIRCULATION
    SAGACH, VF
    ZHUKOVA, AV
    BRAQUET, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S85 - S89
  • [9] SYNTHESIS OF PLATELET-ACTIVATING-FACTOR BY HUMAN MONOCYTES STIMULATED BY PLATELET-ACTIVATING-FACTOR
    VALONE, FH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 87 (03) : 715 - 720
  • [10] HUMAN-PLASMA PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE - ASSOCIATION WITH LIPOPROTEIN PARTICLES AND ROLE IN THE DEGRADATION OF PLATELET-ACTIVATING-FACTOR
    STAFFORINI, DM
    MCINTYRE, TM
    CARTER, ME
    PRESCOTT, SM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (09) : 4215 - 4222